[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338277-105":59,"doc-detail-338277-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cancer-risk-among-patients-with-multiple-sclerosis-a-10-year-nationwide-retrospective-cohort-study","Cancer Risk Among Patients With Multiple Sclerosis - A 10-Year Nationwide Retrospective Cohort Study","","This open access retrospective matched cohort study evaluates cancer risk in people with multiple sclerosis (PwMS) compared with a matched sample from the French general population. Using nationwide French administrative health data covering 2012–2021, the study estimates time to first incident cancer and calculates overall and cancer-type specific hazard ratios. Results show a small overall increase in risk, with differences by age and by cancer location, plus lower participation in national cancer screening programs among PwMS.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancer-risk-among-patients-with-multiple-sclerosis-a-10-year-nationwide-retrospective-cohort-study/338277/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancer-risk-among-patients-with-multiple-sclerosis-a-10-year-nationwide-retrospective-cohort-study/338277.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How did the study compare cancer risk in PwMS with the general population?","Question",{"text":112,"@type":113},"It used a 4:1 matched cohort design comparing PwMS with matched controls from the French general population, then estimated time to the first incident cancer and hazard ratios for overall and cancer-specific outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What did the study find about overall cancer risk in PwMS?",{"text":117,"@type":113},"Cancer incidence was higher in PwMS than controls, with a small overall risk increase (HR 1.06, 95% CI 1.03–1.08), particularly among women.",{"name":119,"@type":110,"acceptedAnswer":120},"Did cancer risk and screening participation vary by age or cancer type?",{"text":121,"@type":113},"Yes. Risk differed by cancer location, and patterns varied by age, including higher risk for PwMS under 55 and lower risk at 65+. PwMS had fewer people receiving screening than controls across the national programs, especially among those aged 65 and older.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338277,1790852994,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","RESEARCH ARTICLE  OPEN ACCESS  \nCancer Risk Among Patients With Multiple Sclerosis  \nA 10-Year Nationwide Retrospective Cohort Study  \nChloe Pierret, MSc, Aurelien Mulliez, MSc, Christine Le Bihan-Benjamin, MD, PhD, Xavier Moisset, MD, PhD, Philippe-Jean Bousquet, MD, PhD, and Emmanuelle Leray, PhD  \nNeurology ® 2024;103:e209885 . doi:10 . 1212/WNL.0000000000209885  \nCorrespondence Chloe Pierret [chloe.pierret@ehesp.fr](chloe.pierret@ehesp.fr)  \nAbstract  \nBackground and Objectives  \nPrevious literature has been diverging on cancer risk in people with multiple sclerosis (PwMS) . Therefore, this study compared the risk of cancer in PwMS and a matched sample from the French general population.  \nMethods  \nThis 10-year nationwide retrospective matched cohort study (2012–2021) used data from the national French administrative health care database (99% coverage of the French population) to determine the time to the ﬁrst incident cancer. PwMS were identiﬁed using their long-term disease (LTD) status, hospitalizations, and multiple sclerosis (MS)–speciﬁc drug reimbursements. The control population was matched 4:1 on age, sex, residence, insurance scheme, and cohort entry date. Participants were included if they had no history of cancer in the 3 years before inclusion. Patients with cancer were identiﬁed through LTD status, hospitalizations, chemotherapy, radiotherapy, or prostate cancer–speciﬁc drug reimbursements. Overall and cancer location–speciﬁc hazard ratios (HRs) for the ﬁrst incident cancer were obtained from Fine and Gray models, and age- and sex-stratiﬁed estimates were reported. Participation in cancer screening through the 3 national programs (breast, colorectal, and cervical) were compared between groups.  \nResults  \nCancer incidence was 799 per 100,000 person-years (PYs) (n = 8,368) among the 140,649 PwMS and 736 per 100,000 PYs (n = 31,796) among the 562,596 matched controls (70.8% of women; follow-up: 7.6 ± 3.2 years) . A small overall risk increase was observed for PwMS (HR 1.06, 95% CI 1.03–1.08), mostly in women (HR 1.08, 95% CI 1.05–1.11) . Risk varied by cancer types and was lower for prostate (HR 0.80, 95% CI 0.73–0.88), breast (HR 0.91, 95% CI 0.86–0.95), and colorectal (HR 0.90, 95% CI 0.84–0.97) cancer and higher for bladder (HR 1.71, 95% CI 1.54–1.89), brain (HR 1.68, 95% CI 1.42–1.98), and cervical (HR 1.24, 95% CI 1.12–1.38) cancer in PwMS. Cancer risk was higher in PwMS younger than 55 years (HR 1.20, 95% CI 1.15–1.24) but decreased in PwMS aged 65 years and older (HR 0.89, 95% CI 0.85–0.94) . This trend was found in all cancer locations. There were fewer PwMS getting screened than controls (all programs), with a particularly pronounced diﬀerence among those aged 65 years and older.  \nDiscussion  \nCancer risk was slightly increased in PwMS, particularly for urogenital cancers, possibly due to surveillance bias. Risk ﬂuctuated depending on age, perhaps due to varying generational screening practices (i.e., diagnosis neglect in the older PwMS) and risk factors.  \nFrom the EHESP, CNRS, Inserm, ARENES UMR 6051, RSMS U 1309 (C.P., E. L.), Rennes University; Clermont-Ferrand University Hospital Center (A.M., X. M.); Survey, Data Science and Assessment Division (C.L.B.-B., P.-J.B.), French National Cancer Institute-InCA, Boulogne-Billancourt; and NeuroDol U1107 (X. M.), Clermont Auvergne University, Clermont-Ferrand, France.  \n[Go to Neurology.org/N for](Go to Neurology.org/N for) full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.  \nThe Article Processing Charge was funded by the authors.  \nThis is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.  \nCopyright © 2024 The","cbCaiqd6Jku42fWL","https://ap.wps.com/l/cbCaiqd6Jku42fWL","pdf",902245,13,"English","# Abstract\n## Background and Objectives\n## Methods\n## Results\n## Discussion\n# Introduction","[{\"question\":\"How did the study compare cancer risk in PwMS with the general population?\",\"answer\":\"It used a 4:1 matched cohort design comparing PwMS with matched controls from the French general population, then estimated time to the first incident cancer and hazard ratios for overall and cancer-specific outcomes.\"},{\"question\":\"What did the study find about overall cancer risk in PwMS?\",\"answer\":\"Cancer incidence was higher in PwMS than controls, with a small overall risk increase (HR 1.06, 95% CI 1.03–1.08), particularly among women.\"},{\"question\":\"Did cancer risk and screening participation vary by age or cancer type?\",\"answer\":\"Yes. Risk differed by cancer location, and patterns varied by age, including higher risk for PwMS under 55 and lower risk at 65+. PwMS had fewer people receiving screening than controls across the national programs, especially among those aged 65 and older.\"}]","Cancer Risk Among Patients With Multiple Sclerosis - A 10-Year Nationwide Retrospective Cohort Study | PDF",1790022883,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ed428b39e42c5a879804966e6f28278.webp",983,1295,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a58133b1ec19d005f734816ac477e7bf.webp",982,1293,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2359c9195d05a9c0ec8587d781b6d291.webp",981,1292,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6471e985f72ad6864a9ca3de4be00e8a.webp",980,1291]